Boston Scientific (NYSE:BSX) today announced the acquisition of Obsidio and its blood vessel embolization material technology. The financial details of the deal were not disclosed. Obsidio develops gel embolic material (GEM) technology that is used for the embolization of blood vessels in the peripheral vasculature. It is a semi-solid, gel-link … [Read more...] about Boston Scientific acquires Obsidio and its gel embolic material